Jump Financial’s Supernus Pharmaceuticals SUPN Stock Holding History

Jump Financial’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.68M	Buy	+100,602	New	+$4.83M	0.04%	549
2025 Q4	–	Sell	-6,155	Closed	-$294K	–	2282
2025 Q3	$294K	Buy	+6,155	New	+$248K	﹤0.01%	1497
2024 Q3	–	Sell	-33,770	Closed	-$903K	–	2100
2024 Q2	$903K	Buy	+33,770	New	+$979K	0.02%	860
2023 Q3	–	Sell	-28,300	Closed	-$851K	–	2245
2023 Q2	$851K	Buy	+28,300	New	+$990K	0.03%	763
2021 Q4	–	Sell	-12,838	Closed	-$342K	–	1703
2021 Q3	$342K	Buy	+12,838	New	+$345K	0.02%	603

Other funds holding SUPN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Jump Financial's SUPN Position: Q2 2026 in Review

Jump Financial opened a new position in Supernus Pharmaceuticals (SUPN) in Q2 2026: 100,602 shares worth $4.68M. The stake represents 0.04% of the portfolio and ranks #549 among its holdings. This is a return to the name: Jump Financial previously reported a position in SUPN as recently as Q3 2025.

Jump Financial first reported a position in SUPN in Q3 2021 and has held it in 5 quarters since. 334 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

Jump Financial held 100,602 shares of Supernus Pharmaceuticals worth $4.68M as of Q2 2026.
Supernus Pharmaceuticals was a new Jump Financial position in Q2 2026.
Supernus Pharmaceuticals made up 0.04% of Jump Financial's portfolio in Q2 2026, its #549 holding.
Jump Financial first reported a position in Supernus Pharmaceuticals in Q3 2021 and has held it in 5 quarters since.
334 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.